Sunday, January 3, 2021

DGCI gives permission to Bharat Biotech for manufacturing Covaxin

https://ift.tt/eA8V8J

The Drugs Controller General of India (DCGI) on Sunday gave licensing permission to Bharat Biotech to manufacture Covaxin, news agency ANI reported. Bharat Biotech has been asked to submit updated safety, efficacy and immunogenicity data from the ongoing Phase I, II and Ill clinical trials till the completion of trials, it further said.



from https://www.thetimesofbengal.com/dgci-gives-permission-to-bharat-biotech-for-manufacturing-covaxin/
via The Times of Bengal | An exclusive 24*7 daily news portal RSS Feed

No comments:

Post a Comment